FDA Adverse Event Malfunction Summary report: N

MRSASELECT

MDR report key: 7607905 · Received June 15, 2018

Report

Report Number
3022521-2018-00005
Event Type
Malfunction
Date Received
June 15, 2018
Date of Event
May 30, 2018
Report Date
June 15, 2018
Manufacturer
BIO-RAD LABORATORIES
Product Code
JSO
UDI-DI
03610520002933
PMA / PMN Number
K081212
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
OTHER

Narratives

Description of Event or Problem · 1

ON MAY 31, 2018, BIO-RAD LABORATORIES - (B)(4) OPERATIONS WAS MADE AWARE OF AN ISSUE WITH MRSASELECT AND (B)(6) SELECTII MEDIA PLATES. THESE PRODUCTS ARE SELECTIVE AND DIFFERENTIAL CHROMOGENIC MEDIA FOR THE QUALITATIVE DETECTION OF (B)(6) COLONIES. FOLLOWING REPORTS FROM THREE CUSTOMERS LOCATED OUTSIDE OF THE U.S., CONCERNING AN ABNORMAL COLORATION OF CERTAIN AGAR PLATES AND THE GROWTH OF NON-CHARACTERISTIC (B)(6) COLONIES, BIO-RAD LABORATORIES (INFECTIOUS DISEASE DIVISION, LOCATED IN (B)(4)) CONDUCTED AN INVESTIGATION AND CONFIRMED THAT CERTAIN LOTS MAY BE AT RISK FOR THIS ISSUE. TO DATE, BIO-RAD LABORATORIES INFECTIOUS DISEASE DIVISION HAS IDENTIFIED THE FOLLOWING KEY FEATURES OF THIS PRODUCT ISSUE: THE ORIGIN OF THE PROBLEM IS ISOLATED TO CERTAIN RAW MATERIALS. THE OBSERVATION OF A NON-CHARACTERISTIC COLORATION OF AGAR AND NON-CHARACTERISTIC (B)(6). COLONIES (COLONIES WITHOUT ANY PINK COLOR DEVELOPMENT) OCCURS WHEN THE MEDIA PLATES HAVE BEEN EXPOSED TO LIGHT FOR PROLONGED PERIODS DURING USE AND STORAGE. FOR MRSASELECT, THE ISSUE PRESENTS AFTER EXPOSURE PERIODS GREATER THAN 2 HOURS. FOR MRSASELECT II, THE ISSUE PRESENTS AFTER EXPOSURE PERIODS GREATER THAN 4 HOURS. MEDIA PLATES WITH ABNORMAL COLORATION MAY BE VISUALLY IDENTIFIED BY THE USER AND MAY BE DETECTED PRIOR TO INOCULATION. IF PLATES WERE EXPOSED TO LIGHT FOR TIME PERIODS EXCEEDING THOSE STATED ABOVE, THEN (B)(6) COLONIES MAY APPEAR WHITE TO YELLOW INSTEAD OF THE PINK CHARACTERISTIC COLOR, OR COLONY GROWTH MAY BE DELAYED. AS A RESULT, THERE IS A RISK OF MISINTERPRETATION OF THE RESULT (POSSIBLE (B)(6)). IN ORDER TO MITIGATE RISK TO RESULTS, BIO-RAD LABORATORIES HAS RECOMMENDED THE FOLLOWING ACTIONS TO ALL CUSTOMERS, DISTRIBUTED IN THE FORM OF A CUSTOMER LETTER: AS ALREADY RECOMMENDED IN THE PACKAGE INSERT, PLEASE ENSURE THAT EXPOSURE OF AGAR PLATES TO LIGHT IS MINIMIZED, BOTH BEFORE AND DURING INCUBATION, WITH THE ADDED TIME RESTRICTIONS AS FOLLOWS: FOR MRSASELECT, DO NOT EXPOSE THE AGAR PLATES TO LIGHT FOR MORE THAN 2 HOURS DURING STORAGE, WARMING, INCUBATION, AND READING. FOR MRSASELECTII, DO NOT EXPOSE THE AGAR PLATES TO LIGHT FOR MORE THAN 4 HOURS DURING STORAGE, WARMING, INCUBATION, AND READING. DO NOT USE AGAR WITH A CHANGE IN COLOR FROM WHITE TO AN ORANGE-PINKISH SHADE. AS RECOMMENDED IN THE PACKAGE INSERT, IF IN DOUBT, CONFIRM THE IDENTIFICATION OF COLONIES BY COAGULASE TEST OR PASTOREX STAPH-PLUS. THE INITIAL COMPLAINT WAS RECEIVED FROM A CUSTOMER IN (B)(6) ON THE OUTSIDE-U.S. VERSION OF MRSA SELECT II (CAT. NO. 63759). A SUBSEQUENT COMPLAINT WAS RECEIVED FROM A (B)(6) CUSTOMER ON THE OUTSIDE-U.S VERSION OF MRSASELECT (CAT. NO. 63757). THEREFORE, BIO-RAD IS FILING TWO U.S. MDR REPORTS FOR THE U.S. VERSION OF MRSASELECT AND MRSASELECTII (CAT NO. 63747 AND 63758, RESPECTIVELY) EVEN THOUGH NO INCIDENTS WERE REPORTED INVOLVING U.S. VERSIONS OF THESE DEVICES. THIS DECISION IS MADE AS PER SECTION 4.11.3 OF THE FDA GUIDANCE "MEDICAL DEVICE REPORTING FOR MANUFACTURERS," WHICH STATES THAT AN EVENT THAT OCCURS IN A FOREIGN COUNTRY IS REPORTABLE IF THE DEVICE IN QUESTION IS SIMILAR TO A DEVICE CLEARED IN THE U.S. INVESTIGATION AT THE BIO-RAD LABORATORIES (B)(4) LOCATION, WHICH OCCURRED SUBSEQUENT TO THE INITIAL COMPLAINT, HAS INDICATED THAT RAW MATERIALS IMPLICATED IN THE ENHANCED LIGHT SENSITIVITY ISSUE WERE ALSO USED IN BOTH MRSASELECT AND MRSASELECT II PRODUCTS DISTRIBUTED BOTH OUTSIDE-U.S. AND WITHIN U.S. ALTHOUGH NO COMPLAINTS HAVE BEEN RECEIVED AGAINST THE U.S. VERSION OF MRSASELECT (CAT. NO. 63747), THIS REPORT IS BEING SUBMITTED IN ORDER TO EXERCISE AN ABUNDANCE OF CAUTION AND TO SATISFY THE REQUIREMENT AS DESCRIBED IN SECTION 4.11.3 OF THE AFOREMENTIONED GUIDANCE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
446978 MRSASELECT MRSASELECT JSO BIO-RAD LABORATORIES 64179161 03610520002933

Patients

Seq Age Sex Outcome Treatment
1